Creative Peptides Provides Synthetic Peptides for Developing Vaccines

Aug 3, 2020

Creative Peptides recently announced that it can provide synthetic peptides for vaccine development.

Shirley, United States - August 3, 2020 /MarketersMedia/ —

In the current COVID-19 pandemic, synthetic peptides play an important role in vaccine development. Creative Peptides, a supplier mainly engaged in the production of biologically active peptides, recently announced that it can provide synthetic peptides for vaccine development.

Coronavirus contains at least four structural proteins, namely spike protein (S), envelope protein (E), membrane protein (M) and nucleocapsid protein (N). The main function of the nucleocapsid protein (N) is to package the viral RNA genome in the virus envelope into a ribonucleoprotein (RNP) complex called the capsid. In addition, the N protein of SARS-CoV-2 affects the response of host cells and may play a regulatory role in the virus life cycle. Creative Peptides provides SARS-CoV-2 Nucleoprotein, SARS-CoV-2 Spike glycoprotein, and SARS-CoV-2 Membrane protein and other peptide products that can be used in vaccine research and immunoassay development.

RGD peptide is a tripeptide sequence composed of L-arginine, glycine and L-aspartic acid, which is a common element in cell recognition. RGD peptide is the binding motif of fibronectin and cell adhesion molecules. RGD peptides can act as inhibitors of integrin-ligand interactions, and induce apoptosis in the absence of signal and integrin-mediated cell clusters.

Antimicrobial peptides are a variety of natural molecules, also called host defense peptides, which are produced by all multicellular organisms as the first line of defense. Antimicrobial peptides have been proven to kill Gram-negative and Gram-positive bacteria, enveloped viruses, fungi, and even cancer cells. Natural AMP is unstable, has a short half-life, has some toxic and side effects, and may also have serious hemolytic activity. Therefore, in order to apply AMP to the clinic, it is necessary and important to develop stable and durable AMP analogs.

FLAG peptide is an eight amino acids peptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) with an enterokinase-cleavage site. It is designed for antibody-mediated identification and purification of recombinant proteins. 3X FLAG Peptide is a synthetic peptide with a 3-time repeated DYKXXD motif.

Angiotensin is composed of at least three polypeptide hormones: Angiotensin I (Ang I), Angiotensin II (Ang II) and Angiotensin III (Ang III). Angiotensin I is derived from a protein secreted by the liver through the action of renin. Ang II is an effective blood pressure regulator, which can regulate blood pressure and maintain total blood volume and salt homeostasis. It controls the release of antidiuretic hormone (ADH) and aldosterone. Angiotensin II is the precursor of angiotensin III, which in turn stimulates the release of aldosterone from the adrenal glands. Angiotensin II not only plays an important role in the etiology of hypertension, but also plays an important role in the pathophysiology of human cardiovascular diseases.

Creative Peptides has developed a wide range of products and services for scientists to accelerate the development of drugs and vaccines for COVID-19 / SARS-CoV-2. For more information, please visit the website: https://www.creative-peptides.com/covid-19-services-and-products.html.

About Creative Peptides
As a US-based expert aimed at creating a better and healthier world for the human beings together with concerted efforts from many industries, Creative Peptides keeps enriching its peptide related products and services in the last two decades, with a comprehensive product range covering cosmetic peptides, catalog peptides, checkpoint inhibitors, therapeutic peptides as well as a one-stop peptide synthesis, modification and analysis service, including Stapled Peptide Synthesis, Long Peptides Synthesis, Cyclic Peptide synthesis, Oligopeptide Synthesis, Post-translational Modification, Peptide Drug Discovery, Peptide Lead Optimization, etc.

Contact Info:
Name: Cathy Miller
Email: Send Email
Organization: Creative Peptides
Address: 45-16 Ramsey Road, Shirley, New York 11967
Website: https://www.creative-peptides.com

Source URL: https://marketersmedia.com/creative-peptides-provides-synthetic-peptides-for-developing-vaccines/88970990

Source: MarketersMedia

Release ID: 88970990

More News

In the US-China AI race, the real fight is keeping humans in control
Sep 28, 2026
In the US-China AI race, the real fight is keeping humans in control

The US-China AI competition faces a dilemma. Both countries see artificial intelligence as a source of economic, scientific and strategic power, so neither has much incentive to slow down. Yet the more capable and autonomous AI becomes, the more important the question of human control. Last week’s summit between US President Donald Trump and Chinese President Xi Jinping brought that tension into the open. Trump wants to leave AI “exactly where it is” rather than add new guardrails, while Xi...

Trump Offered to Sell Arms to China, U.S. Ambassador Says
Sep 28, 2026
Trump Offered to Sell Arms to China, U.S. Ambassador Says

President Trump made the offer to Xi Jinping, China’s leader, said David Perdue, the ambassador to China. The White House later said the U.S. had no plans for such a sale.

Two of China’s EV Makers Announce a Deal as Auto Industry Moves Toward Consolidation
Sep 28, 2026
Two of China’s EV Makers Announce a Deal as Auto Industry Moves Toward Consolidation

Two of the country’s leading makers of electric vehicles announced they are merging their battery swapping and charging operations.

Is AUKUS Too Big to Fail?
Sep 28, 2026
Is AUKUS Too Big to Fail?

The AUKUS partnership survived the Trump transition, and for Canberra it may be too big a deal to ever let fail.

What South Korea Means by Protecting ‘Diverse Families’
Sep 28, 2026
What South Korea Means by Protecting ‘Diverse Families’

A record family ministry budget proposal expands support beyond the traditional household, but a bill to recognize unmarried civil partnerships remains under review.

India’s Sheikh Hasina Dilemma
Sep 28, 2026
India’s Sheikh Hasina Dilemma

New Delhi’s difficult decision serves as a masterclass in how personal diplomacy can trap a major power.

Options for the Royal Brunei Air Force’s Fast-jet Decision
Sep 28, 2026
Options for the Royal Brunei Air Force’s Fast-jet Decision

One important mantra for the RBAirF: Don’t try to run before you can walk.

Europe’s Read of the Trump-Xi Summit
Sep 28, 2026
Europe’s Read of the Trump-Xi Summit

Decisions taken in Washington and Beijing increasingly shape European trade, technology, energy, and security.

Lee Asks Trump to Help Revive North Korea Talks During New York Trip
Sep 28, 2026
Lee Asks Trump to Help Revive North Korea Talks During New York Trip

During a Lee-Trump meeting at the U.N. General Assembly, Seoul said the U.S. president reaffirmed his willingness to talk with North Korean leader Kim Jong Un.

The Trump-Xi Summit Is Over, But Taiwan Is Still Bracing for the Fallout
Sep 28, 2026
The Trump-Xi Summit Is Over, But Taiwan Is Still Bracing for the Fallout

Given what happened in May, Taiwanese may have been more nervous after the latest Trump-Xi summit ended.

Why Pakistan Turned on the Taliban (and Vice Versa)
Sep 28, 2026
Why Pakistan Turned on the Taliban (and Vice Versa)

Why did Pakistan declare “an open war” against its one-time protégé?

Chinese chip foundry CanSemi’s IPO oversubscribed 2,360 times as investors chase AI boom
Sep 28, 2026
Chinese chip foundry CanSemi’s IPO oversubscribed 2,360 times as investors chase AI boom

Chinese chip foundry CanSemi Technology’s Shenzhen initial public offering (IPO) is emerging as one of mainland China’s most sought-after tech listings this year, as investors bet on its push into silicon photonics and its role in domestic artificial intelligence infrastructure. The Guangzhou-based company’s retail tranche was oversubscribed by more than 2,300 times after clawback, according to a stock exchange filing late on Sunday, as investors scrambled for a piece of the domestic...

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Indo Inquirer

Indo Inquirer is the leading online news network in Indonesia, providing daily breaking news with in-depth news coverage and the best photojournalism. We deliver compelling and diverse engaging stories around the world.

Newsletter